-
P+F Products + Features goes U.S. – first implantation of the TricValve® Transcatheter Bicaval Valves System
TricValve® Transcatheter Bicaval Valves System Today P+F Products + Features GmbH announced that the first implantation of its Breakthrough technology, the TricValve® Transcatheter Bicaval Valves System, was recently performed under the guidance of Samir Kapadia MD, Interventional Cardiologist and Chairman, Dept. of Cardiovascular Medicine and Rishi Puri MD PhD, Interventional Cardiologist, at Cleveland Clinic, Ohio, USA. The successful procedure in a patient with longstanding severe tricuspid regurgitation and right heart failure was performed under conscious sedation and TTE guidance. “It’s a great pleasure and honor to perform the first Tricvalve implantation in US at such an outstanding institution as the Cleveland Clinic together with the amazing team of Drs. Samir…
-
P+F Products + Features GmbH gains CE Mark approval for TricValve® Transcatheter Bicaval Valves System
TricValve® Transcatheter Bicaval Valves System made in Europe Today P+F Products + Features GmbH announced that it achieved the CE Mark for its medical device, the TricValve® Transcatheter Bicaval Valves System. It is the first bicaval transcatheter valve system worldwide that has been accredited with the CE Mark. Besides the CE Mark the TricValve has been granted the FDA Breakthrough Device Designation in December 2020, thus confirming the uniqueness of the device. The TricValve® Transcatheter Bicaval Valves is a system of two self-expanding biological valves for the treatment of patients with hemodynamically relevant tricuspid insufficiency and caval reflux. “It is a huge milestone to receive the CE Mark for the…